Skip to content

Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective

Daniel Meling, Milan Scheidegger

Frontiers in Psychology April 3, 2023 DOI: 10.3389/fpsyg.2023.1100058 via OpenAlex

Summary

AI-generated from the abstract

Psychedelics are psychoactive substances whose effects involve changes in biochemistry, brain activity, and subjective experience, but how these levels relate is debated. Two current views are the integration view and the pluralistic view. This article proposes an enactive perspective that re-evaluates the molecule-brain-experience relationship. It applies the concept of autonomy to the causal link between the drug and brain activity, and dynamic co-emergence to the link between brain activity and experience. This enactive view emphasizes interdependence and circular causality across multiple levels, supporting and enriching the pluralistic view by offering a principled account of how layered processes interact. It has implications for understanding causality in psychedelic therapy and research.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Keywords Perspective graphical Causality physics Autonomy Epistemology Cognitive science
Citations 17
Key finding An enactive perspective on psychedelics emphasizes interdependence and circular causality between molecule, brain, and experience, enriching the pluralistic view.

Abstract

Psychedelics are psychoactive substances that receive renewed interest from science and society. Increasing empirical evidence shows that the effects of psychedelics are associated with alterations in biochemical processes, brain activity, and lived experience. Still, how these different levels relate remains subject to debate. The current literature presents two influential views on the relationship between the psychedelic molecule, neural events, and experience: The integration view and the pluralistic view. The main aim of this article is to contribute a promising complementary view by re-evaluating the psychedelic molecule-brain-experience relationship from an enactive perspective. We approach this aim via the following main research questions: (1) What is the causal relationship between the psychedelic drug and brain activity? (2) What is the causal relationship between brain activity and the psychedelic experience? In exploring the first research question, we apply the concept of autonomy to the psychedelic molecule-brain relationship. In exploring the second research question, we apply the concept of dynamic co-emergence to the psychedelic brain-experience relationship . Addressing these two research questions from an enactive position offers a perspective that emphasizes interdependence and circular causality on multiple levels. This enactive perspective not only supports the pluralistic view but enriches it through a principled account of how multi-layered processes come to interact. This renders the enactive view a promising contribution to questions around causality in the therapeutic effects of psychedelics with important implications for psychedelic therapy and psychedelic research.

Comments

No comments yet.

Log in to comment